Attached files
| file | filename |
|---|---|
| EX-5.1 - REPROS THERAPEUTICS INC. | v209412_ex5-1.htm |
| EX-1.1 - REPROS THERAPEUTICS INC. | v209412_ex1-1.htm |
| EX-4.12 - REPROS THERAPEUTICS INC. | v209412_ex4-12.htm |
| EX-4.13 - REPROS THERAPEUTICS INC. | v209412_ex4-13.htm |
| EX-4.11 - REPROS THERAPEUTICS INC. | v209412_ex4-11.htm |
| EX-4.10 - REPROS THERAPEUTICS INC. | v209412_ex4-10.htm |
| S-1/A - REPROS THERAPEUTICS INC. | v209412_s1a.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby
consent to the incorporation by reference in this Amendment No.1 to the
Registration Statement on Form S-1 of Repros Therapeutics Inc. of our report
dated March 15, 2010 relating to the consolidated financial statements and the
effectiveness of internal control over financial reporting, which appears in
Repros Therapeutics Inc.'s Annual Report on Form 10-K for the year ended
December 31, 2009. We also consent to the reference to us under the
heading “Experts” in this Registration Statement.
/s/
PricewaterhouseCoopers LLP
Houston,
Texas
February 1, 2011